General Contents:
Medications as a fundamental Right to human health. Test data. National and MERCOSUR policies in the economic-health field linked to drugs. Current legal system and new health biological issues. Free Trade Agreements (FTAs) in Latin America and its consequences in the national patent systems. Comparative and international law. Extension of patent term due to delays in the granting or delays in marketing approval. Data protection. The Doha Declaration.